Viewing StudyNCT00257608



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00257608
Status: COMPLETED
Last Update Posted: 2016-04-18
First Post: 2005-11-21

Brief Title: A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer ATLAS
Sponsor: Genentech Inc
Organization: Genentech Inc

Conditions & Keywords Data

Conditions:
Name
Non-Small Cell Lung Cancer
Keywords:
Name View
NSCLC View
Lung Cancer View
ATLAS View
Avastin View
Tarceva View